Published on
December 28, 2023
- 11:00 GMT
Oxidien Pharmaceuticals Announces Completion of Asset Sale
LEXINGTON, MA, USA, December 28, 2023 /EINPresswire.com/ -- Oxidien Pharmaceuticals (“Oxidien”) announced today that it has completed the sale of its enzyme technologies and enzyme therapeutic assets. The buyer, Orenzymes LLC, is a private …
Distribution channels:
Healthcare & Pharmaceuticals Industry
...
